Markovitz Lab

Date Certified: December 17, 2024
Description
Our laboratory currently has three main projects – one studies the biochemically distinct DEK protein, which is involved in cancer causation, hematopoiesis, and the pathogenesis of juvenile arthritis. Another project involves working with a molecularly engineered banana lectin that shows promise as a broad-spectrum antiviral agent and an anti-cancer agent. Our third project involves studies of the pathogenesis of scleroderma. {Originally certified gold: June 15, 2015}